XRTX
XORTX Therapeutics·NASDAQ
--
--(--)
--
--(--)
XRTX fundamentals
XORTX Therapeutics (XRTX) released its earnings on Nov 17, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.13 (YoY +55.17%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-0.13
+55.17%
Report date
Nov 17, 2025
EPS
Actual | 6.7941 | -1.2496 | -0.8439 | -1.245 | -2.2749 | -0.99 | -0.81 | -0.67 | 1.38 | -1.24 | 0.06 | -0.29 | -0.04 | -0.19 | -0.19 | -0.13 |
Forecast | -0.853 | -1.4927 | -1.2676 | -1.5374 | -2.1786 | -1.3102 | -1.5571 | -2.0406 | -0.676 | -0.4484 | -0.501 | -0.3831 | -0.29 | -0.27 | -0.25 | -0.1671 |
Surprise | +896.49% | +16.29% | +33.43% | +19.02% | -4.42% | +24.44% | +47.98% | +67.17% | +304.14% | -176.54% | +111.98% | +24.30% | +86.21% | +29.63% | +24.00% | +22.20% |
Revenue
Actual | -- | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is XORTX Therapeutics's latest dividend and current dividend yield?What factors drove the changes in XORTX Therapeutics's revenue and profit?Did XORTX Therapeutics beat or miss consensus estimates last quarter?What does XORTX Therapeutics do and what are its main business segments?What were the key takeaways from XORTX Therapeutics’s earnings call?What is the revenue and EPS growth rate for XORTX Therapeutics year over year?What were the key takeaways from XORTX Therapeutics's earnings call?What guidance did XORTX Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
